【摘 要】
：
Objective Type Ⅰ Takayasu arteritis is a progressive imflammatory disease involving the long segment of aortic arch and its branches.If untreated,which may result in cerebral ischemia and present with
【机 构】
：
Department of Vascular Surgery, Peking Union Medical College Hospital, Peking Union Medical College,
【出 处】
：
中国脑卒中大会2016暨第六届全国心脑血管病论坛、2016中国脑卒中大会中西医结合心脑血管病论坛、世界中医药学会联合会脑
论文部分内容阅读
Objective Type Ⅰ Takayasu arteritis is a progressive imflammatory disease involving the long segment of aortic arch and its branches.If untreated,which may result in cerebral ischemia and present with ranging from hemiplegia to death.Whilst there is a relatively strong evidence to recommend staged bypass for Type I Takayasu arteritis as the simultaneous multi-supra-aortic arteries (SMSAA) bypass was still controversial.In this study,we share our experience on the SMSAA bypass.Methods: From April 2010 to November 2015,12 consecutive patients including 58 aorta branch lesions (severe stenosis>70% or occlusion) presenting with severe cerebral or upper limb ischemia symptoms and underwent SMSAA bypass including 27 grafts,10 with great saphenous vein (GSV),17 with artificial blood vessel (ABV).The disease inflammatory activity was evaluated and anti-inflammatory medication (steroids,methotrexate,or azathioprine,or both) were implemented.During perioperative period,it was intensified by intravenous steroids.Blood pressure was carefully monitored and aimed to 10%-20% lower than pre-operation.We reviewed the clinical features,lesion characteristic,operation information and follow up results.EQ-5D questionnaire was used to evaluate the improvement of the life quality.
其他文献
目的：制备联合检测血清CCL18、CXCLI抗原、CID、TM4SFI、FXRI、TIZIgG型自身抗体液态悬浮芯片.方法：将CCL18、CXCLI单克隆抗体、CID、TM4SFI、FXRI、TIZ蛋白分别偶联聚乙烯微球,同时制备检测用生物素化抗体,优化反应体系使建立的液态悬浮芯片达到最佳的稳定性；用制备好的液态悬浮芯片和ELISA法分别检测并用液态悬浮芯片发和ELISA法分别检测了正常体检妇女、
目的：探讨寄生性平滑肌瘤的病因、临床表现、诊断、治疗及预后。方法：回顾性分析我院3例诊断为寄生性平滑肌瘤病例,结合复习国内外有关寄生性肌瘤报道的多篇文献,总结有关寄生性肌瘤病因、临床表现、病理、诊断、治疗及预后等。结果：3例患者均有腹腔镜下子宫肌瘤剔除术病史,患者均无明显不适,1例寄生于腹壁并逐渐增大,另两例均寄生于盆腔非子宫部位生长,3例均行手术治疗,术后病理均提示子宫平滑肌瘤,术后预后均良好。
目的：液态悬浮芯片法检测血清CCL18、CXCLI抗原、CID、TM4SFI、FXRI、TIZIgG型自身抗体的含量对卵巢癌的诊断临床应用研究.方法：液态悬浮芯片法检测120例健康体检妇女、204例卵巢良性肿瘤患者血清、119例盆腔恶性肿瘤患者、乳腺癌、肝癌、肺癌各40例血清内CCL18、CXCLI抗原、CID、TM4SFI、FXRI、TIZIgG型自身抗体的含量.分别建立联合检测六指标诊断盆腔恶
目的：应用双容积重建透明模式评价颅内动脉瘤介入栓塞的致密度，减少动脉瘤的再出血，提高疗效。方法：2014年2月至2016年2月共119例颅内动脉瘤患者接受介入栓塞治疗，前交通动脉瘤47例，后交通动脉瘤27例，大脑中动脉分叉处动脉瘤15例，眼动脉瘤6例，胼周动脉瘤5例，椎动脉V4段动脉瘤5例，颈内动脉分叉处动脉瘤4例，小脑后下动脉瘤3例，小脑上动脉瘤2例，小脑前下动脉瘤1例；应用西门子Artis z
目的：探讨神经导航在基底节区高血压脑出血手术中的应用前景.方法：回顾性分析我科2012年1月-2012年12月25例应用神经导航的基底节区高血压脑出血手术患者25例,其中钻孔血肿腔置管引流7例,经侧裂显微手术清除血肿15例,经颞叶皮层入路显微手术清除血肿3例.结果：钻孔血肿腔置管7例引流手术时间40～110min,平均65±22min,显微手术18例140～230min,平均195±38min.1
目的：分析翻转式颈动脉内膜剥脱术(eCEA)及颈动脉内膜剥脱+人工血管补片成形术(pCEA)治疗颅外段颈动脉狭窄患者的安全性、有效性及治疗成本。方法：回顾性分析北京协和医院血管外科2009年10月至2015年10月行颈动脉内膜剥脱术的441例颈动脉狭窄患者资料，所有患者按手术方式不同分为eCEA组和pCEA组。